1887
Letter Open Access
Like 0
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2022.27.13.2200254
2022-03-31
2022-05-23
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2022.27.13.2200254
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/27/13/eurosurv-27-13-5.html?itemId=/content/10.2807/1560-7917.ES.2022.27.13.2200254&mimeType=html&fmt=ahah

References

  1. Fonager J, Bennedbæk M, Bager P, Wohlfahrt J, Ellegaard KM, Ingham AC, et al. Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022. Euro Surveill. 2022;27(10)2200181.  https://doi.org/10.2807/1560-7917.ES.2022.27.10.2200181  PMID: 35272746 
  2. Yamasoba D, Kimura I, Nasser H, Morioka Y, Nao N, Ito J, et al. Virological characteristics of SARS-CoV-2 BA.2 variant. bioRxiv. 2022:2022.02.14.480335. Preprint.  https://doi.org/10.1101/2022.02.14.480335 
  3. Takashita E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, Fujisaki S, Ito M, et al. Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2. N Engl J Med.2022;386(10):995-8.  https://doi.org/10.1056/NEJMc2119407  PMID: 35263535 
  4. Iketani S, Liu L, Guo Y, Liu L, Chan JF, Huang Y, et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 2022. . Epub ahead of print. https://doi.org/10.1038/s41586-022-04594-4  PMID: 35240676 
  5. Chen J, Wei GW. Omicron BA.2 (B.1.1.529.2): high potential to becoming the next dominating variant. Res Sq.2022:23:rs.3.rs-1362445. Preprint.
  6. Lyngse FP, Kirkeby CT, Denwood M, Christiansen LE, Mølbak K, Møller CH, et al. Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish households. medRxiv. 2022:2022.01.28.22270044. Preprint.  https://doi.org/10.1101/2022.01.28.22270044 
  7. Yu J, Collier AY, Rowe M, Mardas F, Ventura JD, Wan H, et al. Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 variants. N Engl J Med. 2022. . Epub ahead of print. https://doi.org/10.1056/NEJMc2201849  PMID: 35294809 
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error